Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Liquid extraction surface analysis mass spectrometry (LESA-MS) as a novel profiling tool for drug distribution and metabolism analysis: the terfenadine example.

Eikel D, Vavrek M, Smith S, Bason C, Yeh S, Korfmacher WA, Henion JD.

Rapid Commun Mass Spectrom. 2011 Dec 15;25(23):3587-96. doi: 10.1002/rcm.5274.

PMID:
22095508
2.

Conserved valproic-acid-induced lipid droplet formation in Dictyostelium and human hepatocytes identifies structurally active compounds.

Elphick LM, Pawolleck N, Guschina IA, Chaieb L, Eikel D, Nau H, Harwood JL, Plant NJ, Williams RS.

Dis Model Mech. 2012 Mar;5(2):231-40. doi: 10.1242/dmm.008391. Epub 2011 Oct 14.

3.

Liquid extraction surface analysis (LESA) of food surfaces employing chip-based nano-electrospray mass spectrometry.

Eikel D, Henion J.

Rapid Commun Mass Spectrom. 2011 Aug 30;25(16):2345-54. doi: 10.1002/rcm.5107.

PMID:
21766377
4.

The embryonic stem cell test as tool to assess structure-dependent teratogenicity: the case of valproic acid.

Riebeling C, Pirow R, Becker K, Buesen R, Eikel D, Kaltenhäuser J, Meyer F, Nau H, Slawik B, Visan A, Volland J, Spielmann H, Luch A, Seiler A.

Toxicol Sci. 2011 Apr;120(2):360-70. doi: 10.1093/toxsci/kfr001. Epub 2011 Jan 11.

6.

A novel chromatographic method allows on-line reanalysis of the proteome.

Waanders LF, Almeida R, Prosser S, Cox J, Eikel D, Allen MH, Schultz GA, Mann M.

Mol Cell Proteomics. 2008 Aug;7(8):1452-9. doi: 10.1074/mcp.M800141-MCP200. Epub 2008 Apr 29.

7.

Cellular expression and crystal structure of the murine cytomegalovirus major histocompatibility complex class I-like glycoprotein, m153.

Mans J, Natarajan K, Balbo A, Schuck P, Eikel D, Hess S, Robinson H, Simic H, Jonjic S, Tiemessen CT, Margulies DH.

J Biol Chem. 2007 Nov 30;282(48):35247-58. Epub 2007 Sep 26.

8.

Novel valproic acid derivatives with hemoglobin F inducing activity.

Rönndahl G, Mönkemeyer S, Schulze S, Pekrun A, Eikel D, Nau H, Witt O.

Am J Hematol. 2006 May;81(5):374-6.

9.

Novel valproic acid derivatives with potent differentiation-inducing activity in myeloid leukemia cells.

Deubzer H, Busche B, Rönndahl G, Eikel D, Michaelis M, Cinatl J, Schulze S, Nau H, Witt O.

Leuk Res. 2006 Sep;30(9):1167-75. Epub 2006 Feb 28.

PMID:
16510182
12.

Valproic acid induces extracellular signal-regulated kinase 1/2 activation and inhibits apoptosis in endothelial cells.

Michaelis M, Suhan T, Michaelis UR, Beek K, Rothweiler F, Tausch L, Werz O, Eikel D, Zörnig M, Nau H, Fleming I, Doerr HW, Cinatl J Jr.

Cell Death Differ. 2006 Mar;13(3):446-53.

13.

Increased replication of human cytomegalovirus in retinal pigment epithelial cells by valproic acid depends on histone deacetylase inhibition.

Michaelis M, Suhan T, Reinisch A, Reisenauer A, Fleckenstein C, Eikel D, Gümbel H, Doerr HW, Nau H, Cinatl J Jr.

Invest Ophthalmol Vis Sci. 2005 Sep;46(9):3451-7.

PMID:
16123451
14.
15.

Increased human cytomegalovirus replication in fibroblasts after treatment with therapeutical plasma concentrations of valproic acid.

Michaelis M, Köhler N, Reinisch A, Eikel D, Gravemann U, Doerr HW, Nau H, Cinatl J Jr.

Biochem Pharmacol. 2004 Aug 1;68(3):531-8.

PMID:
15242819
16.

Liposomal daunorubicin (DaunoXome) in multiple myeloma: a modified VAD regimen using short-term infusion.

Eucker J, Eikel D, Heider U, Jakob C, Zavrski I, Gatz F, Mergenthaler HG, Jungclas H, Possinger K, Sezer O.

Anticancer Drugs. 2003 Nov;14(10):793-9.

PMID:
14597873

Supplemental Content

Support Center